The Antidiabetic Agent Acarbose Improves Anti-PD-1 and Rapamycin Efficacy in Preclinical Renal Cancer.Rachael M. Orlandella,William J. Turbitt,Justin T. Gibson,Shannon K. Boi,Peng Li,Daniel L. Smith,Lyse A. NorianCancers（2020）引用 13|浏览12暂无评分关键词kidney cancer,glucose,immunity,nutrition,immunotherapyAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
